CORMEDIX INC. Financing Cash Flow
CORMEDIX INC. (CRMD) reported Financing Cash Flow of -$19.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- CORMEDIX INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$7.07M, a 108.49% decline year-over-year.
- CORMEDIX INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$12.10M, a 298.54% decline year-over-year.
- CORMEDIX INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.41M, a 112.52% decline year-over-year.
- CORMEDIX INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $150.53M, a 969.54% increase year-over-year.
- CORMEDIX INC. net cash provided by (used in) financing activities for fiscal 2025 was $238.45M, a 806.01% increase from fiscal 2024.
- CORMEDIX INC. net cash provided by (used in) financing activities for fiscal 2024 was $26.32M, a 52.93% decline from fiscal 2023.
- CORMEDIX INC. net cash provided by (used in) financing activities for fiscal 2023 was $55.92M, a 212.42% increase from fiscal 2022.
- CORMEDIX INC. net cash provided by (used in) financing activities for fiscal 2022 was $17.90M, a 57.14% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 59 month | Net Cash Provided by (Used in) Financing Activities 62 month | Net Cash Provided by (Used in) Financing Activities 65 month | Net Cash Provided by (Used in) Financing Activities 68 month | Net Cash Provided by (Used in) Financing Activities 71 month | Net Cash Provided by (Used in) Financing Activities 74 month | Net Cash Provided by (Used in) Financing Activities 77 month | Net Cash Provided by (Used in) Financing Activities 80 month | Net Cash Provided by (Used in) Financing Activities 83 month | Net Cash Provided by (Used in) Financing Activities 89 month | Net Cash Provided by (Used in) Financing Activities 92 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$19.17M 10-Q · filed 2026-08-13 | -$20.58M derived: sum of 3 quarters · filed 2026-08-13 | $129.95M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2026-03-31 | -$12.10M 10-Q · filed 2026-05-14 | -$13.51M derived: sum of 2 quarters · filed 2026-05-14 | $137.02M derived: sum of 3 quarters · filed 2026-05-14 | $220.26M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $149.12M derived: sum of 2 quarters · filed 2026-03-05 | $232.36M derived: sum of 3 quarters · filed 2026-08-13 | $238.45M 10-K · filed 2026-03-05 | ||||||||||||||
| 2025-09-30 | $150.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $233.77M derived: sum of 2 quarters · filed 2026-08-13 | $239.87M 10-Q · filed 2025-11-12 | $251.15M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-06-30 | $83.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $89.34M 10-Q · filed 2026-08-13 | $89.34M 10-Q · filed 2025-08-07 | $100.62M derived: sum of 3 quarters · filed 2026-08-13 | $114.70M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||
| 2025-03-31 | $6.09M 10-Q · filed 2026-05-14 | $6.09M 10-Q · filed 2025-05-06 | $17.38M derived: sum of 2 quarters · filed 2026-05-14 | $31.45M derived: sum of 3 quarters · filed 2026-05-14 | $32.51M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | $11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $25.36M derived: sum of 2 quarters · filed 2026-03-05 | $26.42M derived: sum of 3 quarters · filed 2026-03-05 | $26.32M 10-K · filed 2026-03-05 | $26.32M 10-K · filed 2025-03-25 | |||||||||||||
| 2024-09-30 | $14.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $15.13M derived: sum of 2 quarters · filed 2025-11-12 | $15.03M 10-Q · filed 2025-11-12 | $15.50M derived: sum of 4 quarters · filed 2025-11-12 | ||||||||||||||
| 2024-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $959.47K 10-Q · filed 2025-08-07 | $1.43M derived: sum of 3 quarters · filed 2025-08-07 | $44.33M derived: sum of 4 quarters · filed 2025-08-07 | ||||||||||||||
| 2024-03-31 | -$97.12K 10-Q · filed 2025-05-06 | $370.53K derived: sum of 2 quarters · filed 2025-05-06 | $43.27M derived: sum of 3 quarters · filed 2025-05-06 | $48.62M derived: sum of 4 quarters · filed 2025-05-06 | ||||||||||||||
| 2023-12-31 | $467.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $43.37M derived: sum of 2 quarters · filed 2025-03-25 | $48.72M derived: sum of 3 quarters · filed 2025-03-25 | $55.92M 10-K · filed 2025-03-25 | ||||||||||||||
| 2023-09-30 | $42.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $48.25M derived: sum of 2 quarters · filed 2024-10-30 | $55.45M 10-Q · filed 2024-10-30 | $61.49M derived: sum of 4 quarters · filed 2024-10-30 | ||||||||||||||
| 2023-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $12.55M 10-Q · filed 2024-08-14 | $18.60M derived: sum of 3 quarters · filed 2024-08-14 | $19.03M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||
| 2023-03-31 | $7.20M 10-Q · filed 2024-05-09 | $13.25M derived: sum of 2 quarters · filed 2024-05-09 | $13.68M derived: sum of 3 quarters · filed 2024-05-09 | $22.09M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||||||
| 2022-12-31 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $6.48M derived: sum of 2 quarters · filed 2024-03-12 | $14.89M derived: sum of 3 quarters · filed 2024-03-12 | $17.90M 10-K · filed 2024-03-12 | ||||||||||||||
| 2022-09-30 | $437.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $8.85M derived: sum of 2 quarters · filed 2023-11-14 | $11.85M 10-Q · filed 2023-11-14 | $11.85M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||||
| 2022-06-30 | $8.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $11.42M 10-Q · filed 2023-08-08 | $11.42M derived: sum of 3 quarters · filed 2023-08-08 | $11.42M derived: sum of 4 quarters · filed 2023-08-08 | ||||||||||||||
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-15 | $3.00M derived: sum of 2 quarters · filed 2023-05-15 | $3.00M derived: sum of 3 quarters · filed 2023-05-15 | $3.18M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $176.99K derived: sum of 3 quarters · filed 2023-03-30 | $41.76M 10-K · filed 2023-03-30 | ||||||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $176.99K derived: sum of 2 quarters · filed 2022-11-10 | $41.76M 10-Q · filed 2022-11-10 | $57.08M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||
| 2021-06-30 | $176.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $41.76M 10-Q · filed 2022-08-11 | $57.08M derived: sum of 3 quarters · filed 2022-08-11 | $79.02M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||||
| 2021-03-31 | $41.58M 10-Q · filed 2022-05-12 | $56.90M derived: sum of 2 quarters · filed 2022-05-12 | $78.85M derived: sum of 3 quarters · filed 2022-05-12 | $78.85M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||
| 2020-12-31 | $15.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $37.27M derived: sum of 2 quarters · filed 2022-03-29 | $37.27M derived: sum of 3 quarters · filed 2022-03-29 | $40.10M 10-K · filed 2022-03-29 | ||||||||||||||
| 2020-09-30 | $21.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $21.94M derived: sum of 2 quarters · filed 2021-11-09 | $24.78M 10-Q · filed 2021-11-09 | $24.57M derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.83M 10-Q · filed 2021-08-12 | $2.63M derived: sum of 3 quarters · filed 2021-08-12 | $12.66M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||
| 2020-03-31 | $2.83M 10-Q · filed 2021-05-13 | $2.63M derived: sum of 2 quarters · filed 2021-05-13 | $12.66M derived: sum of 3 quarters · filed 2021-05-13 | $12.67M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||
| 2019-12-31 | -$205.93K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $9.82M derived: sum of 2 quarters · filed 2021-03-30 | $9.84M derived: sum of 3 quarters · filed 2021-03-30 | $25.80M 10-K · filed 2021-03-30 | ||||||||||||||
| 2019-09-30 | $10.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.04M derived: sum of 2 quarters · filed 2020-11-05 | $26.01M 10-Q · filed 2020-11-05 | $44.39M derived: sum of 4 quarters · filed 2020-11-05 | ||||||||||||||
| 2019-06-30 | $13.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $15.98M 10-Q · filed 2020-08-10 | $34.37M derived: sum of 3 quarters · filed 2020-08-10 | $41.23M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | $15.97M 10-Q · filed 2020-05-11 | $34.35M derived: sum of 2 quarters · filed 2020-05-11 | $41.21M derived: sum of 3 quarters · filed 2020-05-11 | $42.10M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||||
| 2018-12-31 | $18.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $25.25M derived: sum of 2 quarters · filed 2020-03-16 | $26.13M derived: sum of 3 quarters · filed 2020-03-16 | $29.40M 10-K · filed 2020-03-16 | ||||||||||||||
| 2018-09-30 | $6.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $7.74M derived: sum of 2 quarters · filed 2019-11-14 | $11.01M 10-Q · filed 2019-11-14 | $18.39M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||||||
| 2018-06-30 | $880.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $4.15M 10-Q · filed 2019-08-14 | $11.52M derived: sum of 3 quarters · filed 2019-08-14 | $11.52M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||||||||
| 2018-03-31 | $3.27M 10-Q · filed 2019-05-13 | $10.64M derived: sum of 2 quarters · filed 2019-05-29 | $10.64M derived: sum of 3 quarters · filed 2019-05-29 | $23.44M derived: sum of 4 quarters · filed 2019-05-29 | ||||||||||||||
| 2017-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-29 | $7.37M derived: sum of 2 quarters · filed 2019-05-29 | $20.17M derived: sum of 3 quarters · filed 2019-05-29 | $20.52M 10-K · filed 2019-05-29 | ||||||||||||||
| 2017-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $12.80M derived: sum of 2 quarters · filed 2018-11-14 | $13.15M 10-Q · filed 2018-11-14 | $13.17M derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||||||
| 2017-06-30 | $12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $13.15M 10-Q · filed 2018-08-14 | $13.17M derived: sum of 3 quarters · filed 2018-08-14 | $17.82M derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||||
| 2017-03-31 | $354.16K 10-Q · filed 2018-05-15 | $376.56K derived: sum of 2 quarters · filed 2018-05-15 | $5.03M derived: sum of 3 quarters · filed 2018-05-15 | $7.18M derived: sum of 4 quarters · filed 2018-05-15 | ||||||||||||||
| 2016-12-31 | $22.39K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $4.67M derived: sum of 2 quarters · filed 2018-03-19 | $6.83M derived: sum of 3 quarters · filed 2018-03-19 | $7.09M 10-K · filed 2018-03-19 | ||||||||||||||
| 2016-09-30 | $4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.80M derived: sum of 2 quarters · filed 2017-11-09 | $7.07M 10-Q · filed 2017-11-09 | $8.28M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||
| 2016-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.42M 10-Q · filed 2017-08-09 | $3.63M derived: sum of 3 quarters · filed 2017-08-09 | $6.93M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||||||||
| 2016-03-31 | $265.98K 10-Q · filed 2017-05-10 | $1.47M derived: sum of 2 quarters · filed 2017-05-10 | $4.77M derived: sum of 3 quarters · filed 2017-05-10 | $37.07M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||||||
| 2015-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $4.51M derived: sum of 2 quarters · filed 2017-03-16 | $36.80M derived: sum of 3 quarters · filed 2017-03-16 | $43.63M 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $35.59M derived: sum of 2 quarters · filed 2016-11-09 | $42.42M 10-Q · filed 2016-11-09 | $42.43M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | $32.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $39.12M 10-Q · filed 2016-08-04 | $39.13M derived: sum of 3 quarters · filed 2017-03-16 | $39.23M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $6.83M 10-Q · filed 2016-05-10 | $6.84M derived: sum of 2 quarters · filed 2017-03-16 | $6.93M derived: sum of 3 quarters · filed 2017-03-16 | $6.93M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | $8.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $104.50K derived: sum of 2 quarters · filed 2017-03-16 | $104.50K derived: sum of 3 quarters · filed 2017-03-16 | $8.36M 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | $95.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $95.80K derived: sum of 2 quarters · filed 2015-11-12 | $8.35M 10-Q · filed 2015-11-12 | $11.21M derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $8.25M 10-Q · filed 2015-08-06 | $11.11M derived: sum of 3 quarters · filed 2015-08-06 | $12.96M derived: sum of 4 quarters · filed 2015-08-06 | ||||||||||||||
| 2014-03-31 | $8.25M 10-Q · filed 2015-05-07 | $11.11M derived: sum of 2 quarters · filed 2015-05-07 | $12.96M derived: sum of 3 quarters · filed 2015-05-07 | $12.98M derived: sum of 4 quarters · filed 2015-05-07 | $38.45M 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.70M derived: sum of 2 quarters · filed 2015-03-12 | $4.73M derived: sum of 3 quarters · filed 2015-03-12 | $5.20M 10-K · filed 2015-03-12 | $30.19M 10-K · filed 2014-03-31 | |||||||||||||
| 2013-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.87M derived: sum of 2 quarters · filed 2014-11-13 | $2.34M 10-Q · filed 2014-11-13 | $2.71M derived: sum of 4 quarters · filed 2014-11-13 | $27.33M 10-Q/A · filed 2014-03-04 | |||||||||||||
| 2013-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $500.00K 10-Q · filed 2014-08-14 | $871.40K derived: sum of 3 quarters · filed 2014-08-14 | $1.64M derived: sum of 4 quarters · filed 2014-08-14 | $25.49M 10-Q/A · filed 2014-03-04 | |||||||||||||
| 2013-03-31 | $475.00K 10-Q · filed 2014-05-15 | $846.40K derived: sum of 2 quarters · filed 2014-05-15 | $1.62M derived: sum of 3 quarters · filed 2014-05-15 | $1.60M derived: sum of 4 quarters · filed 2014-05-15 | $25.47M 10-Q/A · filed 2014-03-04 | |||||||||||||
| 2012-12-31 | $371.40K derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-31 | $1.14M derived: sum of 2 quarters · filed 2014-03-31 | $1.13M derived: sum of 3 quarters · filed 2014-03-31 | $1.13M 10-K · filed 2014-03-31 | $24.99M 10-K/A · filed 2014-03-04 | |||||||||||||
| 2012-09-30 | $770.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04 | $755.00K derived: sum of 2 quarters · filed 2014-03-04 | $755.00K 10-Q/A · filed 2014-03-04 | $755.00K derived: sum of 4 quarters · filed 2014-03-04 | $24.62M 10-Q/A · filed 2013-03-27 | |||||||||||||
| 2012-06-30 | -$15.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2014-03-04 | -$15.00K 10-Q/A · filed 2014-03-04 | -$15.00K derived: sum of 3 quarters · filed 2014-03-04 | -$15.00K derived: sum of 4 quarters · filed 2014-03-04 | $23.85M 10-Q/A · filed 2012-09-06 | |||||||||||||
| 2012-03-31 | $0.00 10-Q/A · filed 2014-03-04 | $0.00 derived: sum of 2 quarters · filed 2014-03-04 | $0.00 derived: sum of 3 quarters · filed 2014-03-04 | $23.86M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-27 | $0.00 derived: sum of 2 quarters · filed 2013-03-27 | $0.00 10-K · filed 2013-03-27 | $23.86M 10-K/A · filed 2012-04-26 | ||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-03-27 | $0.00 10-Q/A · filed 2013-03-27 | $23.86M 10-Q · filed 2011-11-10 | |||||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | $23.86M 10-Q · filed 2011-08-09 | ||||||||||||||||
| 2010-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-04-26 | $0.00 derived: sum of 2 quarters · filed 2012-04-26 | $10.46M 10-K/A · filed 2012-04-26 | |||||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $10.46M 10-Q · filed 2011-11-10 | ||||||||||||||||
| 2010-06-30 | $10.46M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |